0001761468-23-000001.txt : 20231106 0001761468-23-000001.hdr.sgml : 20231106 20231106143055 ACCESSION NUMBER: 0001761468-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231106 DATE AS OF CHANGE: 20231106 EFFECTIVENESS DATE: 20231106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cytonus Therapeutics, Inc. CENTRAL INDEX KEY: 0001761468 IRS NUMBER: 811664855 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-496564 FILM NUMBER: 231379483 BUSINESS ADDRESS: STREET 1: 111 E. DESHLER AVE. CITY: COLUMBUS STATE: OH ZIP: 43206 BUSINESS PHONE: 631-258-4070 MAIL ADDRESS: STREET 1: 111 E. DESHLER AVE. CITY: COLUMBUS STATE: OH ZIP: 43206 D 1 primary_doc.xml X0708 D LIVE 0001761468 Cytonus Therapeutics, Inc. 3280 Grey Hawk Ct. Carlsbad CA CALIFORNIA 92010 631-258-4070 DELAWARE None None Corporation true 2018 Remo Moomiaie c/o Cytonus Therapeutics, Inc. 3280 Grey Hawk Ct. Carlsbad CA CALIFORNIA 92010 Executive Officer Director Richard Klemke c/o Cytonus Therapeutics, Inc. 3280 Grey Hawk Ct. Carlsbad CA CALIFORNIA 92010 Executive Officer Director Christopher Thorne c/o Cytonus Therapeutics, Inc. 3280 Grey Hawk Ct. Carlsbad CA CALIFORNIA 92010 Director Jae An c/o Cytonus Therapeutics, Inc. 3280 Grey Hawk Ct. Carlsbad CA CALIFORNIA 92010 Director Biotechnology Decline to Disclose 06b false 2023-10-27 false true false 0 21603089 11703095 9899994 Total Amount Sold includes $5,099,963.24 of new cash and $6,603,131.67 of converted indebtedness. false 19 0 0 0 false Cytonus Therapeutics, Inc. /s/ Remo Moomiaie Remo Moomiaie Chief Executive Officer 2023-11-03